Previous 10 | Next 10 |
SOLANA BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has received 510(k) clearance for its SmartF...
2024-01-12 21:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-10 14:43:33 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Small-cap stocks are set to have their day in the sun this year, and not just because favorable economic and monetary policy conditions are set to put wind in their sales. Instead, investors ar...
2024-01-09 10:00:06 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and utilities could perform better in 2024 - analyst For further details see: Cyc...
2024-01-08 16:47:48 ET More on ClearPoint Neuro NeuroOne: A Hidden Contender Against ClearPoint In The Brain Drug Delivery Arena ClearPoint Neuro, Inc. (CLPT) Q3 2023 Earnings Call Transcript ClearPoint Neuro, Inc. 2023 Q3 - Results - Earnings Call Presentation ...
SOLANA BEACH, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced preliminary, unaudited financial results for its fourth quarter a...
2023-11-14 08:00:00 ET Summary Both NeuroOne and ClearPoint Neuro are emerging as significant players in the neurological device sector, each carving out their own niche, with ClearPoint focusing on drug delivery and NeuroOne advancing. NeuroOne is rapidly positioning itself as a ...
2023-11-09 19:38:09 ET ClearPoint Neuro, Inc. (CLPT) Q3 2023 Earnings Conference Call November 09, 2023 04:30 PM ET Company Participants Joe Burnett - Chief Executive Officer Danilo D'Alessandro - Chief Financial Officer Conference Call Participants Mathe...
2023-11-09 16:19:38 ET More on ClearPoint Neuro ClearPoint Neuro Continues To Make Progress Seeking Alpha’s Quant Rating on ClearPoint Neuro Historical earnings data for ClearPoint Neuro Financial information for ClearPoint Neuro For further de...
SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its third quarter ended September 30, ...
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
ClearPoint Neuro, Inc. Website:
SOLANA BEACH, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its ...
2024-07-15 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...